These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 263291)

  • 1. Opiates, prolactin, and the dopamine receptor.
    Tolis G; Dent R; Guyda H
    J Clin Endocrinol Metab; 1978 Jul; 47(1):200-3. PubMed ID: 263291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
    Delitala G; Maioli M; Pacifico A; Brianda S; Palermo M; Mannelli M
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1145-9. PubMed ID: 6688812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
    Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
    Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of opiate agonist and antagonist on serum prolactin in primates: possible role for endorphins in prolactin regulation.
    Gold MS; Redmond DE; Donabedian RK
    Endocrinology; 1979 Jul; 105(1):284-9. PubMed ID: 221205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyproheptadine on chlorpromazine stimulation of prolactin in women.
    Board JA; Fierro RJ
    Am J Obstet Gynecol; 1981 Jan; 139(2):160-3. PubMed ID: 6109449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of opiate agonists on growth hormone and prolactin release in rats.
    Shaar CJ; Clemens JA
    Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon.
    Lorenzi M; Tsalikian E; Bohannon NV; Gerich JE; Karam JH; Forsham PH
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1154-8. PubMed ID: 591612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor function in Parkinson's disease--in vivo studies with prolactin responses.
    Laihinen A; Rinne UK
    Adv Neurol; 1987; 45():249-52. PubMed ID: 3103387
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic mechanisms and luteinizing hormone secretion. I. Acute administration of the dopamine agonist bromocriptine does not inhibit luteinizing hormone release in hyperprolactinemic women.
    Evans WS; Rogol AD; MacLeod RM; Thorner MO
    J Clin Endocrinol Metab; 1980 Jan; 50(1):103-7. PubMed ID: 7188612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serotonin in opiate-induced prolactin secretion and antinociception in the developing rat.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):831-6. PubMed ID: 2435887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
    Gerasimov G; Chernova T; Goncharov N
    Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
    Fujita M; Shimizu T
    Bull Osaka Med Sch; 1986 Oct; 32(2):73-84. PubMed ID: 3122863
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that methadone stimulates prolactin release by dopamine receptor blockade.
    Clemens JA; Sawyer BD
    Endocr Res Commun; 1974; 1(4):373-8. PubMed ID: 4462997
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopaminergic and serotonergic involvement in opiate-induced prolactin release in monkeys.
    Wehrenberg WB; McNicol D; Wardlaw SL; Frantz AG; Ferin M
    Endocrinology; 1981 Aug; 109(2):544-7. PubMed ID: 7250056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed activation of tuberoinfundibular dopamine neurons and suppression of prolactin secretion in the rat after morphine administration.
    Gudelsky GA; Passaro E; Meltzer HY
    J Pharmacol Exp Ther; 1986 Mar; 236(3):641-5. PubMed ID: 3950867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.